Jackson Creek Investment Advisors LLC acquired a new position in AdaptHealth Corp. (NASDAQ:AHCO – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 135,198 shares of the company’s stock, valued at approximately $1,466,000. Jackson Creek Investment Advisors LLC owned approximately 0.10% of AdaptHealth as of its most recent SEC filing.
Other large investors also recently made changes to their positions in the company. GAMMA Investing LLC increased its position in shares of AdaptHealth by 175.2% in the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company’s stock worth $81,000 after acquiring an additional 4,758 shares in the last quarter. Guggenheim Capital LLC increased its position in shares of AdaptHealth by 10.1% in the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company’s stock worth $158,000 after acquiring an additional 1,525 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of AdaptHealth in the fourth quarter valued at $169,000. Humankind Investments LLC boosted its stake in shares of AdaptHealth by 18.3% in the fourth quarter. Humankind Investments LLC now owns 17,979 shares of the company’s stock valued at $171,000 after purchasing an additional 2,776 shares during the period. Finally, Proficio Capital Partners LLC purchased a new position in shares of AdaptHealth in the fourth quarter valued at $181,000. Institutional investors and hedge funds own 82.67% of the company’s stock.
AdaptHealth Stock Up 0.8%
NASDAQ AHCO traded up $0.07 during trading hours on Friday, reaching $9.27. 92,206 shares of the company traded hands, compared to its average volume of 1,473,219. AdaptHealth Corp. has a 12 month low of $7.11 and a 12 month high of $11.90. The company has a current ratio of 1.29, a quick ratio of 1.07 and a debt-to-equity ratio of 1.25. The stock has a market capitalization of $1.25 billion, a PE ratio of 16.26, a PEG ratio of 1.06 and a beta of 1.63. The company has a 50 day moving average of $8.98 and a two-hundred day moving average of $9.40.
Analyst Ratings Changes
Get Our Latest Analysis on AdaptHealth
AdaptHealth Profile
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Featured Articles
- Five stocks we like better than AdaptHealth
- Airline Stocks – Top Airline Stocks to Buy Now
- Full Steam Ahead: The Bullish Case for Carnival Stock
- How to Invest in the FAANG Stocks
- The Utilities Sector Is Heating Up—Don’t Miss the Breakout
- Dividend Payout Ratio Calculator
- How Goldman Sachs Earnings Help You Strategize Your Portfolio
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.